Submit Deal

Announced

22 Jun 2015

Completed

24 Sep 2015

ALVOGEN INC / VATERA HEALTHCARE PARTNERS / TEMASEK HOLDINGS (PRIVATE) LIMITED / CVC CAPITAL PARTNERS / PAMPLONA CAPITAL MANAGEMENT / Acquisition / Private

Synopsis

Pamplona Capital Management's sale of a controlling stake in Alvogen, a multinational pharmaceuticals company, to a consortium of investors, including CVC Capital Partners, Temasek and Vatera Healthcare Partners.

Principals

target

Alvogen

bidder

Temasek Holdings

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (4)

brian steinhardt

Partner at Simpson Thacher & Bartlett

Lawyer

target

Deals

£ 223.92 B

Total Value

robert wessman

CEO at ALVOGEN INC

Manager

target

Deals

£ 2.14 B

Total Value

peter martelli

Partner at Simpson Thacher & Bartlett

Lawyer

target

Deals

£ 36.20 B

Total Value

clare gaskell

Partner at Simpson Thacher & Bartlett

Lawyer

target

Deals

£ 45.67 B

Total Value

Bidder Team (3)

ho ching

CEO at TEMASEK HOLDINGS LIMITED

Investor

bidder

Deals

£ 59.01 B

Total Value

tomas ekman

Partner at CVC CAPITAL PARTNERS

Investor

bidder

Deal

n/a

Total Value

kevin thomas ferro

Founder and CEO at VATERA HEALTHCARE PARTNERS

Investor

bidder

Deal

n/a

Total Value

Vendor Team (1)

jeremy gelber

Partner at PAMPLONA CAPITAL MANAGEMENT

Investor

vendor

Deals

£ 2.81 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy